Coronavirus
The Absence of Long COVID Treatment Plans Has Become a New Business Opportunity for Medium-sized Pharmas
2022-03-30
Mu COVID Variant Could Potentially Escape Immunity But Delta is Still “Most Concerning”, WHO Says
2021-09-08
Monoclonal Antibodies for COVID-19: AstraZeneca and Regeneron’s Therapies Endure Contrasting Fortunes
2021-06-16
COVID-19: Rise in UK Cases Trigger Global Concerns Over “Highly Infectious” Delta Variant
2021-06-14
India’s COVID Crisis Roundup: Eli Lilly Collaborates with 3 Local Drugmakers to Upscale Baricitinib
2021-05-11
LATEST
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115